122
Participants
Start Date
September 1, 2019
Primary Completion Date
September 30, 2020
Study Completion Date
August 31, 2021
HealthSpan
The intervention was conducted on a group of healthy volunteers of age 29-85 with a once-daily administration of the oral capsule containing the active ingredients, for three consecutive months.
Placebo
The intervention was conducted on a group of healthy volunteers of age 29-85 with a once-daily administration of the placebo, for three consecutive months.
Institute of Chemical Biology of National Hellenic Research Foundation, Athens
Theracell Advanced Biotechnology
UNKNOWN
National Hellenic Research Foundation
OTHER